Alabama Medicaid Home

Drug Utilization Review (DUR) Board

Drug Utilization Review (DUR) is designed to improve the quality of pharmaceutical care by ensuring that prescriptions are appropriate, medically necessary and unlikely to result in adverse medical outcomes. Medicaid’s DUR program includes prospective, online and retrospective review as well as use of standards developed by the National Council for Prescription Drug Programs (NCPDP). A board comprised of physicians and pharmacists provides guidance to Agency staff.

About the Board  

Board Meetings

October 21, 2026, Agenda

This is a meeting of Alabama Medicaid's Drug Utilization Review Board in which Prospective and Retrospective Drug Utilization Review are reviewed. The DUR program is designed to educate physicians and pharmacists to identify and reduce the frequency of patterns of fraud, abuse, gross overuse, or inappropriate or medically unnecessary care among physicians and pharmacists.

The October 21, 2026,  Drug Utilization Review (DUR) Board Meeting will be held in a hybrid format, offering both in-person attendance at the Alabama Medicaid building in Montgomery, Alabama, and virtual participation via Webex. Voting board members may attend either onsite or remotely. Please see the virtual Webex link provided below on the Alabama Medicaid website. All DUR Board meetings are open to the public.

Join from the meeting link

https://medicaid.webex.com/medicaid/j.php?MTID=me0c64a497458905a949b726c899a5067

 

Join by meeting number

Meeting number (access code): 2661 695 0666

Meeting password: 4sNv2ysv2X5

 

Tap to join from a mobile device (attendees only)  
+1-650-479-3208,,26616950666## United States Toll 

Join by phone  
+1-650-479-3208 United States Toll  

 

 

  •  

    DUR Board Minutes 2017-2026

  •